Jennifer Chow
Seminars
Wednesday 3rd December 2025
Industry Leaders Fireside Chat: What’s Happened in the Last Year & Where is the Field Headed Next?
8:40 am
- Examining the evolution of the autoimmune cell therapy field over the last year
- Discussing progress across autologous, allogeneic, NK and in vivo modalities to uncover development strategies
- Considering indication selection strategies and the potential for indication diversification beyond lupus
- Exploring the future of the field to effectively scale and commercialise safe, durable therapies
Wednesday 3rd December 2025
Demonstrating Durable Remission in Lupus with iCell Gene Therapeutics’ Dual-Target, Armored CAR-T Therapy
3:30 pm
- Introducing iCell Gene Therapeutics’ ICG318 CD-19—BCMA/IL-15 compound CAR-T
- Evaluate the synergistic impact of combined B-cell and plasma cell depletion in enhancing durability of response
- Highlight iCell Gene Therapeutics’ 5+ year long-term follow-up data, to define what therapeutic durability looks like in lupus patients
